DNA Based Vaccine Expressing SARS-CoV-2 Spike-CD40L Fusion Protein Confers Protection Against Challenge in a Syrian Hamster Model
Levi Tamming(Health Canada), Xuguang Li(Health Canada)
Cited by 20
Related Papers
Targeting CD40 enhances antibody- and CD8-mediated protection against respiratory syncytial virus infection
|Scientific Reports|2018|11
Impurity Removal Leading to High-Performance CoSb<sub>3</sub>-Based Skutterudites with Synergistic Carrier Concentration Optimization and Thermal Conductivity Reduction
|ACS Applied Materials & Interfaces|2021|11
Synthetic vaccine affords full protection to mice against lethal challenge of influenza B virus of both genetic lineages
|iScience|2021|10
Single Immunization of a Vaccine Vectored by a Novel Recombinant Vaccinia Virus Affords Effective Protection Against Respiratory Syncytial Virus Infection in Cotton Rats
|Frontiers in Immunology|2021|9
Lipid nanoparticle encapsulation of a Delta spike-CD40L DNA vaccine improves effectiveness against Omicron challenge in Syrian hamsters
|Molecular Therapy — Methods & Clinical Development|2024|6